Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03717116
Other study ID # 83045809-604.01.02, A-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2017
Est. completion date December 1, 2018

Study information

Verified date October 2018
Source Istanbul University
Contact selen soylu
Phone +905375653811
Email selen_soylu@yahoo.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Hypocalcemia is the most frequent complication in thyroid surgeries. Diagnosing this complication earlier will reduce longer hospital stay and will lead to an earlier intervention. The purpose of the study is to evaluate postoperative second hour parathyroid hormone measurement as a predictor for early stage hypocalcemia.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date December 1, 2018
Est. primary completion date October 31, 2018
Accepts healthy volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- patients with multinodular goiter, Graves, fine needle aspiartion biopsy with Bethesda 3-4 undergoing total thyroidectomy

Exclusion Criteria:

- pregnant women

- patients with thyroid cancer or previous neck dissection

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
parathormone level
From the patients, blood will be taken preoperatively and postoperatively.

Locations

Country Name City State
Turkey Istanbul University Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative parathormone level postoperative 2. hour